Tünde Nagy - Concepedia

Author

Tünde Nagy

Also Known As

István Nagy T., Krajcsi, Peter, Nagy, Tamás István, T NAGY, T Nagy, T. NAGY, T. Nagy, Tamas Nagy, Tamás István Nagy, Tess Nagy

Publications

1.7K

Citations

H-Index

103

Concepts

All Affiliations

Solvo Biotechnology (Hungary)University of Szeged National Institute of Oncology Hungarian Academy of Sciences Institute of Biochemistry

About

Tünde Nagy is an author at Solvo Biotechnology (Hungary) specializing in medicine, pharmacology, and biochemistry.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	13	15	1.1K
2	Language Studies	3	3	72
3	Education	2	2	55
4	Health Sciences	2	2	128
5	Engineering	1	1	17

Tünde Nagy

Publications

1.6K

Citations

H-Index

Page 1

	Year	Citations
Overall survival in the OlympiA phase III trial of adjuvant olaparib in patients with germline pathogenic variants in BRCA1/2 and high-risk, early breast cancer Charles E. Geyer, Judy E. Garber, Richard D. Gelber, Annals of Oncology Breast OncologyOverall SurvivalMedicinePathologyGermline Pathogenic Variants	2022	404
Interaction of ivermectin with multidrug resistance proteins (MRP1, 2 and 3) Anne Lespine, Jacques Dupuy, Stéphane Orlowski, Chemico-Biological Interactions Multidrug Resistance ProteinsMedicineImmunologyBiomolecular InteractionProtein Transport	2005	121
Cholesterol Potentiates ABCG2 Activity in a Heterologous Expression System: Improved in Vitro Model to Study Function of Human ABCG2 Ákos Pál, Dóra Méhn, E. M. Molnar, Journal of Pharmacology and Experimental Therapeutics	2007	107
Detoxification function of aldose/aldehyde reductase during drought and ultraviolet‐B (280–320 nm) stresses Éva Hideg, Tünde Nagy, Attila Oberschall, Plant Cell & Environment Aldo-keto ReductaseRedox BiologyDetoxification FunctionOxidative StressAldose/aldehyde Reductase	2003	100
Effect of Membrane Cholesterol on BSEP/Bsep Activity: Species Specificity Studies for Substrates and Inhibitors Emese Kis, Enikő Ioja, Tünde Nagy, Drug Metabolism and Disposition	2009	94
The Gβγ Dimer Drives the Interaction of Heterotrimeric Gi Proteins with Nonlamellar Membrane Structures Oliver Vögler, Jesús Casas, Danita Capó, Journal of Biological Chemistry Proteinlipid InteractionSignal TransductionBiochemistryG Protein-coupled ReceptorNonlamellar Membrane Structures	2004	80
SAPPHIRE: phase III study of sitravatinib plus nivolumab versus docetaxel in advanced nonsquamous non-small-cell lung cancer Hossein Borghaei, Filippo de Marinis, Daphne W. Dumoulin, Annals of Oncology Nivolumab Versus DocetaxelMedicinePharmacologyAnti-cancer AgentPhase Iii Study	2023	78
Membrane Structure Modulation, Protein Kinase Cα Activation, and Anticancer Activity of Minerval Jordi Martínez, Oliver Vögler, Jesús Casas, Molecular Pharmacology	2004	77
Leflunomide and its metabolite A771726 are high affinity substrates of BCRP: implications for drug resistance E. Kis, Tünde Nagy, Marghi Jani, Annals of the Rheumatic Diseases	2008	73
Cetuximab, gemcitabine and capecitabine in patients with inoperable biliary tract cancer: A phase 2 study Gábor Rubovszky, István Láng, Erna Ganofszky, European Journal of Cancer Surgical OncologyGastrointestinal OncologyMedicineBiliary CancerPathology	2013	47

Page 1